Page last updated: 2024-11-04

sulfaphenazole and Methemoglobinemia

sulfaphenazole has been researched along with Methemoglobinemia in 1 studies

Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
THAL, W1
WERNER, U1

Other Studies

1 other study available for sulfaphenazole and Methemoglobinemia

ArticleYear
[METHEMOGLOBINEMIAS OF YOUNG INFANTS DUE TO SULFAMETHOXYPYRIDAZINE].
    Zeitschrift fur arztliche Fortbildung, 1964, May-15, Volume: 58

    Topics: Bronchitis; Cyanosis; Dyspepsia; Infant; Infant, Newborn; Meningitis; Methemoglobinemia; Sulfamethox

1964